Minesh P. Mehta

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.261Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825

Neuro-Oncology(2024)10.1093/neuonc/noae234

Top 59%

0.261DataRank

Top 59%4 citations

Mark R. Gilbert, Minesh P. Mehta, Ang Li, Renke Zhou, Melissa L. Bondy +18 more

Papers

Driven by 31 papers — median percentile 41. Top paper: “Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival”.

Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival

Neuro-Oncology(2020)10.1093/neuonc/noaa025

N/A

2.3DataRank · unranked

77 citations

Shane Mesko, Jing Li, Daniel Cagney, Ayal A. Aizer, Nancy U. Lin +34 more

Correcting the drug development paradigm for glioblastoma requires serial tissue sampling

Nature Medicine(2023)10.1038/s41591-023-02464-8

N/A

0.604DataRank · unranked

55 citations

Kelly Hotchkiss, Ian F. Parney, John de Groot, Solmaz Sahebjam, Nader Sanai +31 more

A Neuroradiologist’s Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in Adults

American Journal of Neuroradiology(2024)10.3174/ajnr.a8396

N/A

0.533DataRank · unranked

34 citations

Francesco Sanvito, Timothy F. Cloughesy, Raymond Y. Huang, Javier Villanueva-Meyer, Whitney B. Pope +21 more

Cross-sectional survey of patients, caregivers, and physicians on diagnosis and treatment of brain metastases

Neuro-Oncology Practice(2021)10.1093/nop/npab042

N/A

0.373DataRank · unranked

11 citations

Gi-Ming Wang, Kristin Waite, Scott Elder, Avery Fine, Manmeet S. Ahluwalia +11 more

Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses

Research Square(2023)10.21203/rs.3.rs-2663611/v1

N/A

0.330DataRank · unranked

8 citations

William Chen, Abrar Choudhury, Mark W. Youngblood, Mei‐Yin C. Polley, Calixto‐Hope G. Lucas +52 more

Neurocognitive outcomes in patients with brain metastases: a systematic review

The Lancet Oncology(2025)10.1016/s1470-2045(25)00525-x

N/A

0.269DataRank · unranked

5 citations

Sebastian Winter, Kristen A. Batich, Karin Gehring, Michael Parsons, Jörg Dietrich +13 more

Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825

Neuro-Oncology(2024)10.1093/neuonc/noae234

Top 59%

0.261DataRank

Top 59%4 citations

Mark R. Gilbert, Minesh P. Mehta, Ang Li, Renke Zhou, Melissa L. Bondy +18 more

Single-agent ONC201 in recurrent H3 K27M-mutant diffuse midline glioma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3615

N/A

0DataRank · unranked

2 citations

Sylvia C. Kurz, Rohinton S. Tarapore, Ashley Sumrall, Nicholas Butowski, Rebecca A. Harrison +15 more

Long-term analysis of the WHO-defined molecular subgroups of high-risk grade II gliomas treated with radiation and temozolomide on NRG Oncology/RTOG 0424.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2518

N/A

0DataRank · unranked

1 citations

Stephanie L. Pugh, Barbara J. Fisher, Glenn J. Lesser, David R. Macdonald, Jessica L. Fleming +15 more

Systematic review of combinations of targeted or immunotherapy in advanced solid tumors

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002459

N/A

0DataRank · unranked

83 citations

Stephen Bagley, Patrick Y. Wen, Michael Lim, Michael Platten, Howard Colman +16 more

Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions

Neuro-Oncology(2022)10.1093/neuonc/noac118

N/A

0DataRank · unranked

194 citations

Nayan Lamba, Manmeet S. Ahluwalia, Kenneth Aldape, Adrienne Boire, Priscilla K. Brastianos +20 more

Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial

Neuro-Oncology(2022)10.1093/neuonc/noac173

N/A

0DataRank · unranked

153 citations

Stephanie L. Pugh, Tony J. C. Wang, Kenneth Aldape, Hui Gan, Matthias Preusser +27 more

Graded Prognostic Assessment (GPA) for Patients With Lung Cancer and Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA Including the Effect of Programmed Death Ligand 1 and Other Prognostic Factors

International Journal of Radiation Oncology*Biology*Physics(2022)10.1016/j.ijrobp.2022.03.020

N/A

0DataRank · unranked

122 citations

Brian De, Jing Li, David Carpenter, John P. Kirkpatrick, Michael Milligan +35 more

Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.01.051

N/A

0DataRank · unranked

148 citations

Shane Mesko, Jing Li, Daniel Cagney, Ayal A. Aizer, Nancy U. Lin +34 more

Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0131

N/A

0DataRank · unranked

154 citations

Abed Rahman Kawakibi, Sunjong Ji, Sebastian M. Waszak, Stefan R. Sweha, Mateus Mota +79 more

Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses

Nature Medicine(2023)10.1038/s41591-023-02586-z

N/A

0DataRank · unranked

106 citations

Abrar Choudhury, Mark W. Youngblood, Mei‐Yin C. Polley, Calixto‐Hope G. Lucas, Kanish Mirchia +53 more

National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities

The Lancet Oncology(2023)10.1016/s1470-2045(23)00297-8

N/A

0DataRank · unranked

39 citations

Minesh P. Mehta, Dee Dee Smart, Patricia S. Steeg, Julie A. Hong, Michael Graham Espey +39 more

Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference

The Lancet Oncology(2023)10.1016/s1470-2045(23)00005-0

N/A

0DataRank · unranked

26 citations

Mei‐Yin C. Polley, Laura Alder, Priscilla K. Brastianos, Carey K. Anders, Hussein A. Tawbi +9 more

Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology–KROG/RTOG 1119 Phase 2 Randomized Trial

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.07.019

N/A

0DataRank · unranked

18 citations

Kathryn Winter, Paul W. Sperduto, Jennifer F. De Los Santos, David M. Peereboom, Tomi Ogunleye +17 more

Multidisciplinary Management of Isocitrate Dehydrogenase–Mutated Gliomas in a Contemporary Molecularly Defined Era

Journal of Clinical Oncology(2024)10.1200/jco.23.02195

N/A

0DataRank · unranked

11 citations

David Schiff, Arnab Chakravarti, Jessica L. Fleming, Paul D. Brown, Vinay K. Puduvalli +6 more

Evaluating the sensitivity of EQ-5D-5L in patients with brain metastases: a secondary analysis of NRG CC001

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae020

N/A

0DataRank · unranked

2 citations

Melody Qu, Zafar Zafarí, Søren M. Bentzen, Terri S. Armstrong, Vinai Gondi +4 more

Update to the RANO working group and EANO recommendations for the clinical use of PET imaging in gliomas

The Lancet Oncology(2025)10.1016/s1470-2045(25)00193-7

N/A

0DataRank · unranked

30 citations

Philipp Lohmann, Mariam Aboian, Ramon Barajas, William G. Breen, Jana Ivanidze +29 more

Response Assessment in Neuro-Oncology (RANO) 2009–2025: Broad scope and implementation—A progress report

Neuro-Oncology(2025)10.1093/neuonc/noaf118

N/A

0DataRank · unranked

8 citations

Michael A. Vogelbaum, Timothy F. Cloughesy, Norbert Galldiks, Nathalie L. Albert, Joerg-Christian Tonn +30 more

Redefining neurocognitive outcomes after radiation for brain metastases: a patient-level meta-analysis of recovery following initial decline

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf264

N/A

0DataRank · unranked

4 citations

Kai Sun, Søren M. Bentzen, Paul D. Brown, Terri S. Armstrong, Joshua D. Palmer +4 more

Implementation Strategies to Increase Clinical Trial Enrollment in a Community-Academic Partnership and Impact on Hispanic Representation: An Interrupted Time Series Analysis

JCO Oncology Practice(2022)10.1200/op.22.00037

N/A

0DataRank · unranked

27 citations

Diana Lin, Daniel R. Gomez, Jonathan T. Yang, Nancy Y. Lee, Andreas Rimner +19 more

Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition

Acta Neuropathologica(2020)10.1007/s00401-020-02155-5

N/A

0DataRank · unranked

96 citations

Julieann C. Lee, Ajay Ravindranathan, Javier Villanueva-Meyer, Quynh T. Tran, Sariah J. Allen +37 more

Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?

Radiation Research(2020)10.1667/rade-20-00211.1

N/A

0DataRank · unranked

46 citations

Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey C. Buchsbaum, Dörthe Schaue, Arnab Chakravarti +20 more

Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02

Neuro-Oncology Advances(2020)10.1093/noajnl/vdaa124

N/A

0DataRank · unranked

22 citations

John G. Kuhn, Kathleen R. Lamborn, Lauren E. Abrey, Lisa M. DeAngelis, Frank S. Lieberman +14 more

Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients

Neuro-Oncology(2020)10.1093/neuonc/noaa015

N/A

0DataRank · unranked

41 citations

Michael Weller, Joohee Sul, Stephen Bagley, Solmaz Sahebjam, Martin J. van den Bent +19 more

Randomized phase II study of rituximab, methotrexate (MTX), procarbazine, vincristine, and cytarabine (R-MPV-A) with and without low-dose whole-brain radiotherapy (LD-WBRT) for newly diagnosed primary CNS lymphoma (PCNSL).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2501

N/A

0DataRank · unranked

59 citations

Lisa M. DeAngelis, Theodore Karrison, Joe A Bovi, Marc K. Rosenblum, Benjamin W. Corn +16 more

A phase III randomized, double-blind placebo controlled study of armodafinil (Nuvigil) to reduce cancer-related fatigue in patients with high-grade glioma (Alliance A221101).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.12007

N/A

0DataRank · unranked

3 citations

Heshan Liu, Sadhna Kohli, Jane H. Cerhan, Jeff A. Sloan, Ryan P. McMurray +8 more

Minesh P. Mehta

Indexed papers

Top data-sharing exemplar

Papers